Medicis has longstanding experience as an investor in healthcare private equity investing.

The firm’s mission is to provide its technology and market know how as well as its distinctive financial and business network to young and innovative companies employing cutting edge life science technologies or novel health management concepts and/or systems. Jointly with their portfolio companies, they strive to improve the quality and efficiency of the life science and healthcare market.

Medicis currently holds a portfolio of companies in MedTech, Molecular diagnostics and Specialty Pharma.